官方服务：
资源简介：
Supplementary tables and figures
应用场景：
创建时间：
2021-07-23
相关数据集
Supplementary Table SI from Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216
Supplementary Table SI XLS file 19K, Supplementary Table SI: Kinase selectivity of PF-4989216
aacr.figshare.com2023-05-31 更新40
Data_Sheet_1_Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx
Purpose: The role of targeted therapy in the neoadjuvant field of stage IIIA epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) is still controversial. We sou
NIAID Data Ecosystem40
Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase
Mutations in the Ras family of GTP binding proteins represent one of the most frequently observed genetic alterations in human cancers. We and others have recently demonstrated that expression of Met,
PubMed Central2001-09-04 更新20
Supplementary Material for: Sequential Myelomatous Pleural and Pericardial Effusions in Multiple Myeloma: A Case Report Demonstrating Extended Survival with Teclistamab
Abstract Background: Myelomatous pleural effusion (MPE) and pericardial involvement are rare manifestations of multiple myeloma, occurring in less than 1% of cases and carrying historically poor progn
DataCite Commons2025-04-17 更新40
North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
The North America B-Cell Maturation Antigen(BCMA) Targeted Therapies market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provid
IMR REPORTS30
